Results 31 to 40 of about 3,882 (211)

Ketosis in Hepatic Glycogenosis [PDF]

open access: yesArchives of Disease in Childhood, 1972
The occurrence of ketosis in 41 patients with liver glycogenosis and a control group of 22 children was investigated. Fasting ketosis was present in children with a deficiency of the debranching enzyme system and in young children with a deficiency of the phosphorylase system, but never in patients with a glucose-6-phosphatase deficiency.
J, Fernandes, N A, Pikaar
openaire   +2 more sources

Skeletal muscle metabolism during prolonged exercise in Pompe disease

open access: yesEndocrine Connections, 2017
Objective: Pompe disease (glycogenosis type II) is caused by lysosomal alpha-glucosidase deficiency, which leads to a block in intra-lysosomal glycogen breakdown.
Nicolai Preisler   +8 more
doaj   +1 more source

Oral Manifestations in Patients with Glycogen Storage Disease: A Systematic Review of the Literature

open access: yesApplied Sciences, 2020
(1) Background: Glycogen storage disease (GSD) represents a group of twenty-three types of metabolic disorders which damage the capacity of body to store glucose classified basing on the enzyme deficiency involved.
Antonio Romano   +7 more
doaj   +1 more source

Pompe disease, a late-onset – misleading form of diagnosis in a patient with persistent hepatic cytolysis syndrome [PDF]

open access: yesRomanian Journal of Pediatrics, 2020
The article discusses a clinical case of late-onset Pompe disease in a 15-year and 6-month-old adolescent hospitalised in a Paediatric Gastroenterology department to investigate persistent liver cytolysis, without response to hepatoprotective therapy ...
Smaranda Diaconescu   +8 more
doaj   +1 more source

Therapeutic advances in the management of Pompe disease and other metabolic myopathies

open access: yesTherapeutic Advances in Neurological Disorders, 2013
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement therapy (ERT), the first causative treatment for glycogenosis type II (GSDII) or Pompe disease, which has given new impetus to research into that disease
Corrado Angelini   +2 more
doaj   +1 more source

Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant

open access: yesPulmonary Circulation, 2022
We present a case of a late preterm infant placed on extracorporeal life support in the first day of life for persistent pulmonary hypertension of the newborn.
Stephanie M. Tsoi   +7 more
doaj   +1 more source

Related liver fragment transplantation for type 1 glycogenosis: the first Russian experience The paper describes two clinical examples of successful related liver fragment transplantation for type 1 glycogenosis in a one-year-old boy and a 6-year-old girl. The given first successful clinical experience suggests that liver fragments for type 1 glycogenoses can be transplanted from live related donors and offers promise for the radical treatment of patients with this pathology.

open access: yesТрансплантология (Москва), 2018
The paper describes two clinical examples of successful related liver fragment transplantation for type 1 glycogenosis in a one-year-old boy and a 6-year-old girl.
A. V. Filin   +14 more
doaj   +1 more source

Feasibility of resistance training in adult McArdle patients: Clinical outcomes and muscle strength and mass benefits

open access: yesFrontiers in Aging Neuroscience, 2014
We analyzed the effects of a 4-month resistance (weight lifting) training program followed by a 2-month detraining period in 7 adult McArdle patients (5 female) on: muscle mass (assessed by DXA), strength, serum creatine kinase (CK) activity and clinical
Alfredo eSantalla   +7 more
doaj   +1 more source

Lived Experiences of Patients With Rare Diseases and Healthcare System Barriers: A Phenomenological Study

open access: yesJournal of Nursing Management, Volume 2026, Issue 1, 2026.
Aim To explore the lived experiences and perceptions of patients with rare diseases (RD) in relation to the disease process and its management by the healthcare system. Background Although each RD individually affects fewer than 0.05% of the population, collectively RD affect between 3.5% and 5.9% of the global population, representing approximately ...
Pedro Soriano-Martin   +7 more
wiley   +1 more source

Genotyping Brahman cattle for generalised glycogenosis

open access: yes, 2002
Objective: To develop procedures for genotyping Brahman cattle for loss-of-function alleles within the acidic α -glucosidase gene and to assess the risk of generalised glycogenosis in Australian Brahman cattle.
KG REICHMANN   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy